Here is a handy chart comparing the four medications: Atogepant (Qulipta) is FDA approved for prevention of both episodic and chronic migraine. It is an oral medication that is taken daily.

Many of these individuals had received previous migraine treatment (nonsteroidal anti-inflammatory drug-type analgetics or triptans) to which they had failed to respond. Haloperidol was associated ...